Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37


Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.

Beigel JH, Tebas P, Elie-Turenne MC, Bajwa E, Bell TE, Cairns CB, Shoham S, Deville JG, Feucht E, Feinberg J, Luke T, Raviprakash K, Danko J, O'Neil D, Metcalf JA, King K, Burgess TH, Aga E, Lane HC, Hughes MD, Davey RT; IRC002 Study Team..

Lancet Respir Med. 2017 May 15. pii: S2213-2600(17)30174-1. doi: 10.1016/S2213-2600(17)30174-1. [Epub ahead of print]


Mosquito Exposure and Chikungunya and Dengue Infection Among Travelers During the Chikungunya Outbreak in the Americas.

Lindholm DA, Myers T, Widjaja S, Grant EM, Telu K, Lalani T, Fraser J, Fairchok M, Ganesan A, Johnson MD, Kunz A, Tribble DR, Yun HC.

Am J Trop Med Hyg. 2017 Apr;96(4):903-912. doi: 10.4269/ajtmh.16-0635. Epub 2017 Jan 23.


A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria.

Lalani T, Yun H, Tribble D, Ganesan A, Kunz A, Fairchok M, Schnaubelt E, Fraser J, Mitra I, Kronmann KC, Burgess T, Deiss RG, Riddle MS, Johnson MD.

J Travel Med. 2016 Jul 4;23(5). doi: 10.1093/jtm/taw043. Print 2016 May.


Type-specific clinical characteristics of adenovirus-associated influenza-like illness at five US military medical centers, 2009-2014.

Koren MA, Arnold JC, Fairchok MP, Lalani T, Danaher PJ, Schofield CM, Rajnik M, Hansen EA, Mor D, Chen WJ, Ridoré M, Burgess TH, Millar EV.

Influenza Other Respir Viruses. 2016 Sep;10(5):414-20. doi: 10.1111/irv.12392. Epub 2016 May 13.


Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza.

Powers JH, Guerrero ML, Leidy NK, Fairchok MP, Rosenberg A, Hernández A, Stringer S, Schofield C, Rodríguez-Zulueta P, Kim K, Danaher PJ, Ortega-Gallegos H, Bacci ED, Stepp N, Galindo-Fraga A, St Clair K, Rajnik M, McDonough EA, Ridoré M, Arnold JC, Millar EV, Ruiz-Palacios GM.

BMC Infect Dis. 2016 Jan 5;16:1. doi: 10.1186/s12879-015-1330-0.


Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.

Deiss RG, Arnold JC, Chen WJ, Echols S, Fairchok MP, Schofield C, Danaher PJ, McDonough E, Ridoré M, Mor D, Burgess TH, Millar EV.

Vaccine. 2015 Dec 16;33(51):7160-7. doi: 10.1016/j.vaccine.2015.11.004. Epub 2015 Nov 10.


Neuraminidase inhibitor therapy in a military population.

Fairchok MP, Chen WJ, Arnold JC, Schofield C, Danaher PJ, McDonough EA, Ottolini M, Mor D, Ridore M, Burgess TH, Millar EV.

J Clin Virol. 2015 Jun;67:17-22. doi: 10.1016/j.jcv.2015.03.018. Epub 2015 Mar 24.


Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children.

Chen WJ, Arnold JC, Fairchok MP, Danaher PJ, McDonough EA, Blair PJ, Garcia J, Halsey ES, Schofield C, Ottolini M, Mor D, Ridoré M, Burgess TH, Millar EV.

J Clin Virol. 2015 Mar;64:74-82. doi: 10.1016/j.jcv.2015.01.007. Epub 2015 Jan 13.


Molecular epidemiology of respiratory syncytial virus transmission in childcare.

Chu HY, Kuypers J, Renaud C, Wald A, Martin E, Fairchok M, Magaret A, Sarancino M, Englund JA.

J Clin Virol. 2013 Aug;57(4):343-50. doi: 10.1016/j.jcv.2013.04.011. Epub 2013 May 17.


Epidemiology of multiple respiratory viruses in childcare attendees.

Martin ET, Fairchok MP, Stednick ZJ, Kuypers J, Englund JA.

J Infect Dis. 2013 Mar 15;207(6):982-9. doi: 10.1093/infdis/jis934. Epub 2013 Jan 3.


Human Parechovirus and Other Enteric Viruses in Childcare Attendees in the Era of Rotavirus Vaccines.

Braun LE, Renaud C, Fairchok MP, Kuypers J, Englund JA, Martin ET.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):136-43. doi: 10.1093/jpids/pis005. Epub 2012 May 3.


Severe human parechovirus sepsis beyond the neonatal period.

Sainato R, Flanagan R, Mahlen S, Fairchok M, Braun L.

J Clin Virol. 2011 May;51(1):73-4. doi: 10.1016/j.jcv.2011.02.009. Epub 2011 Mar 8.


A prospective study of parainfluenza virus type 4 infections in children attending daycare.

Fairchok MP, Martin ET, Kuypers J, Englund JA.

Pediatr Infect Dis J. 2011 Aug;30(8):714-6. doi: 10.1097/INF.0b013e3182113989.


Epidemiology of viral respiratory tract infections in a prospective cohort of infants and toddlers attending daycare.

Fairchok MP, Martin ET, Chambers S, Kuypers J, Behrens M, Braun LE, Englund JA.

J Clin Virol. 2010 Sep;49(1):16-20. doi: 10.1016/j.jcv.2010.06.013. Epub 2010 Jul 21.


Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?

Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA.

Vaccine. 2010 Jun 17;28(27):4376-83. doi: 10.1016/j.vaccine.2010.04.058. Epub 2010 May 4.


Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.

Hogue JS, Buttke P, Braun LE, Fairchok MP.

J Clin Microbiol. 2010 Jul;48(7):2599-600. doi: 10.1128/JCM.02118-09. Epub 2010 Apr 26.


Frequent and prolonged shedding of bocavirus in young children attending daycare.

Martin ET, Fairchok MP, Kuypers J, Magaret A, Zerr DM, Wald A, Englund JA.

J Infect Dis. 2010 Jun 1;201(11):1625-32. doi: 10.1086/652405.


Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.

Walter EB, Englund JA, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC27 Study Team..

Pediatr Infect Dis J. 2009 Dec;28(12):1099-104. doi: 10.1097/INF.0b013e3181b0c0ca.


Severe morbidity and mortality with breast milk associated cytomegalovirus infection.

Hamele M, Flanagan R, Loomis CA, Stevens T, Fairchok MP.

Pediatr Infect Dis J. 2010 Jan;29(1):84-6. doi: 10.1097/INF.0b013e3181b6dbb5.


Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center.

Perkins D, Hogue JS, Fairchok M, Braun L, Viscount HB.

Mil Med. 2008 Jun;173(6):604-8.


Supplemental Content

Loading ...
Support Center